护士主导的长期糖皮质激素并发症预防项目(COCORTICO)的评估:一项随机试验的研究方案
本研究为在法国五家医院开展的优势性、开放标签、平行组随机试验,比较护士主导的跨学科项目与标准治疗对开始长期糖皮质激素治疗的成人患者的效果。主要终点为52周时由盲法研究者评估的糖皮质激素毒性指数(GTI)累积恶化评分。研究假设该项目可降低长期糖皮质激素毒性负担并改善生活质量。
要点
- 护士主导的跨学科预防项目包括视频教育、护士面谈、营养师咨询、个体化纸质预防措施表、医生用药预防信息表及第12、24、36周电话随访。
- 主要终点为52周时盲法研究者评估的糖皮质激素毒性指数(GTI)累积恶化评分。
- 研究假设该项目可降低长期糖皮质激素毒性负担并改善患者生活质量。
核心结论
- 研究假设护士主导的治疗教育项目可降低长期糖皮质激素毒性负担并改善患者生活质量;若成立,该项目可纳入接受长期糖皮质激素治疗患者的常规照护。
研究设计与样本
- 优势性、开放标签、平行组随机试验,在法国五家医院比较护士主导的跨学科项目与标准治疗。
- 纳入开始首次长期糖皮质激素序列治疗的成人患者,排除肿瘤血液病、严重慢性肾功能衰竭和器官移植患者。
主要发现
- 主要终点为52周时由盲法研究者使用糖皮质激素毒性指数(GTI)累积恶化评分评估的糖皮质激素毒性负担。
- 次要终点包括52周时特定糖皮质激素相关不良事件的发生、生活质量、预防措施的实施及累积糖皮质激素剂量。
关键数值与推荐
- 护士主导预防项目包括:(1)解释糖皮质激素相关不良事件及适当预防措施的视频;(2)与受过培训的护士的个人会面;(3)营养师咨询;(4)总结适合患者的非药物预防措施的个体化纸质表;(5)总结适合治疗医生的药物预防措施的信息纸;(6)第12周、第24周和第36周的电话呼叫以确保预防措施得到充分实施和理解。
- 两组患者均收到总结糖皮质激素治疗相关预防措施的信息纸;对照组接受其医生提供的标准治疗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Long-term glucocorticoids are widely prescribed for autoimmune and inflammatory diseases, but their use is associated with a wide range of adverse events, some of which can be severe. Patient education on toxicity and preventive strategies is essential, yet many patients do not receive sufficient information. In some areas, nurse-led therapeutic programs have been developed to optimize care. However, no standardized, institutionally supported education program exists to prevent the adverse events of long-term glucocorticoid therapy. METHODS: We are conducting a superiority, open-label, parallel-group, randomized trial, comparing a nurse-led interdisciplinary program with standard of care, across five French hospitals. Eligible participants are adult patients initiating a first sequence of long-term glucocorticoids for a medical condition, excluding onco-hematological diseases, severe chronic renal failure and organ transplantation. The nurse-led prevention program consists of the following: (1) a video explaining glucocorticoids-related adverseevents and appropriate preventive measures, (2) a personal meeting with a trained nurse, (3) a consultation with a dietitian, (4) a personalized individual paper sheet summarizing appropriate non-drug preventive measures for the patient, (5) an information paper sheet summarizing appropriate drug preventive measures for the treating physician, and (6) phone calls at week 12, week 24, and week 36 to ensure that the preventive measures are adequately implemented and understood. Patients in both groups receive an information paper sheet summarizing preventive measures related to glucocorticoid therapy. Patients randomized to the control group receive the standard care provided by their physician. The primary endpoint is the burden of glucocorticoid toxicity, evaluated by a blinded investigator using the cumulative worsening score of the Glucocorticoid Toxicity Index (GTI) at 52 weeks. The secondary endpoints are the occurrence of specific glucocorticoid-related adverse events, quality of life, implementation of preventive measures and cumulative glucocorticoid dosage at 52 weeks. DISCUSSION: We hypothesize that this therapeutic education program will reduce the burden of long-term glucocorticoid toxicity and improve patients' quality of life. If so, this program could be implemented in routine care for patients receiving long-term glucocorticoid therapy. TRIAL REGISTRATION: ClinicalTrials.gov NCT04909606. Registered on 2 June 2021, https://clinicaltrials.gov/study/NCT04909606.
引用
- Nicol S, Trin K, Simon LA, et al. Evaluation of a nurse-led program for the prevention of complications of long-term glucocorticoids (COCORTICO): study protocol for a randomized trial. Trials. 2025. PMID: 41250159. doi:10.1186/s13063-025-09236-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。